Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7600
+0.0200 (1.15%)
NASDAQ · Last Trade: Feb 21st, 6:35 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors